168 related articles for article (PubMed ID: 21508169)
41. Unveiling the role of NK cells, NKT-like cells, and γδ cells in pathogenesis of type 1 reactions in leprosy.
Pathak VK; Singh I; Sharma B; Turankar RP; Arora M; Singh SV; Sengupta U
Heliyon; 2024 Feb; 10(3):e25254. PubMed ID: 38327455
[TBL] [Abstract][Full Text] [Related]
42. Macrophages from patients with atopic dermatitis show a reduced CXCL10 expression in response to staphylococcal α-toxin.
Kasraie S; Niebuhr M; Kopfnagel V; Dittrich-Breiholz O; Kracht M; Werfel T
Allergy; 2012 Jan; 67(1):41-9. PubMed ID: 21906079
[TBL] [Abstract][Full Text] [Related]
43. Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients.
Moraes MO; Sarno EN; Teles RM; Almeida AS; Saraiva BC; Nery JA; Sampaio EP
J Invest Dermatol; 2000 Dec; 115(6):935-41. PubMed ID: 11121122
[TBL] [Abstract][Full Text] [Related]
44. Development of Type 2, But Not Type 1, Leprosy Reactions is Associated with a Severe Reduction of Circulating and In situ Regulatory T-Cells.
Vieira AP; Trindade MÂ; Pagliari C; Avancini J; Sakai-Valente NY; Duarte AJ; Benard G
Am J Trop Med Hyg; 2016 Apr; 94(4):721-7. PubMed ID: 26903606
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.
Karason K; Jernås M; Hägg DA; Svensson PA
BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603
[TBL] [Abstract][Full Text] [Related]
46. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
47. Detection of IL-13, IL-10, and IL-6 in the leprosy skin lesions of patients during prednisolone treatment for type 1 (T1R) reactions.
Atkinson SE; Khanolkar-Young S; Marlowe S; Jain S; Reddy RG; Suneetha S; Lockwood DN
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):27-34. PubMed ID: 15217318
[TBL] [Abstract][Full Text] [Related]
48. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
49. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
Berres ML; Trautwein C; Schmeding M; Eurich D; Tacke F; Bahra M; Neuhaus P; Neumann UP; Wasmuth HE
Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880
[TBL] [Abstract][Full Text] [Related]
50. CXCL10, MCP-1, and other immunologic markers involved in neural leprosy.
Medeiros MF; Rodrigues MM; Vital RT; da Costa Nery JA; Sales AM; de Andrea Hacker M; Ferreira H; Chimelli L; Sarno EN; Antunes SL
Appl Immunohistochem Mol Morphol; 2015 Mar; 23(3):220-9. PubMed ID: 25221954
[TBL] [Abstract][Full Text] [Related]
51. CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors.
Rosenblum JM; Shimoda N; Schenk AD; Zhang H; Kish DD; Keslar K; Farber JM; Fairchild RL
J Immunol; 2010 Apr; 184(7):3450-60. PubMed ID: 20194716
[TBL] [Abstract][Full Text] [Related]
52. CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's disease.
Lee SJ; Kang SE; Kang EH; Choi BY; Masek-Hammerman K; Syed J; Zhan Y; Neff-Phillips K; Park JK; Lee EY; Lee EB; Song YW
Sci Rep; 2017 Nov; 7(1):14720. PubMed ID: 29116188
[TBL] [Abstract][Full Text] [Related]
53. Adrenomedullin suppresses tumour necrosis factor alpha-induced CXC chemokine ligand 10 production by human gingival fibroblasts.
Hosokawa I; Hosokawa Y; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2008 Jun; 152(3):568-75. PubMed ID: 18435806
[TBL] [Abstract][Full Text] [Related]
54. Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Sebastiani M; Fallahi P
J Rheumatol; 2010 Jan; 37(1):91-7. PubMed ID: 19918044
[TBL] [Abstract][Full Text] [Related]
55. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
Carter SL; Müller M; Manders PM; Campbell IL
Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
[TBL] [Abstract][Full Text] [Related]
56. Increased expression of interferon-inducible genes in macaque lung tissues during simian immunodeficiency virus infection.
Schaefer TM; Fuller CL; Basu S; Fallert BA; Poveda SL; Sanghavi SK; Choi YK; Kirschner DE; Feingold E; Reinhart TA
Microbes Infect; 2006 Jun; 8(7):1839-50. PubMed ID: 16822691
[TBL] [Abstract][Full Text] [Related]
57. Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions.
Sreenivasan P; Misra RS; Wilfred D; Nath I
Immunology; 1998 Dec; 95(4):529-36. PubMed ID: 9893041
[TBL] [Abstract][Full Text] [Related]
58. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin.
Kaplan G; Luster AD; Hancock G; Cohn ZA
J Exp Med; 1987 Oct; 166(4):1098-108. PubMed ID: 2443597
[TBL] [Abstract][Full Text] [Related]
59. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
60. Interferon-gamma, interleukin-18, monokine induced by interferon-gamma and interferon-gamma-inducible protein-10 in histiocytic necrotizing lymphadenitis.
Ohshima K; Haraoka S; Takahata Y; Takada H; Tsutiya K; Suzuk K; Suzumiya J; Kikuchi M
Leuk Lymphoma; 2002 May; 43(5):1115-20. PubMed ID: 12148894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
